Inflammation and Depression: the Neuroimmune Connection.

Curr Treat Options Psychiatry

University of Texas Dell Medical School, Department of Psychiatry, 1701 Trinity Street, Austin Tx 78712.

Published: December 2018

AI Article Synopsis

  • The field of psychoneuroimmunology highlights the connection between the immune system and depression, indicating that immune dysfunction, particularly inflammation, can significantly affect mood disorders.
  • Early studies suggest that reducing inflammation might improve depressive symptoms and could influence how patients respond to standard treatments.
  • Considering a patient's inflammatory status is crucial in depression management, and while healthy lifestyle changes are beneficial for all, they may be especially vital for those with inflammation; targeted immune therapies are still in the experimental phase but hold promise for future treatment strategies.

Article Abstract

Purpose Of Review: To update clinicians on the field of psychoneuroimmunology with respect to depression.

Recent Findings: A significant subset of patients with depression may have illness to which dysfunction of the immune system, typically viewed as inflammation, makes a significant contribution. Normal sickness behavior may sometimes manifest abnormally as mood episodes. Early evidence suggests that interventions that reduce inflammation may improve symptoms in these patients and that they may also respond differently to standard pharmacotherapy.

Summary: Treatment of patients with depression should consider inflammatory status, as part of medical and psychiatric health. Recommendations for healthy diet and exercise are important for all patients but may be more important for patients who have clinical evidence of inflammation. Methods of identifying patients in the inflammatory subgroup and treating them with therapy targeted specifically at the immune system are still experimental but likely to impact care for depression in the future.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516764PMC
http://dx.doi.org/10.1007/s40501-018-0157-xDOI Listing

Publication Analysis

Top Keywords

patients depression
8
immune system
8
patients
6
inflammation
4
inflammation depression
4
depression neuroimmune
4
neuroimmune connection
4
connection purpose
4
purpose review
4
review update
4

Similar Publications

Context: The use of prebiotics and probiotics as a treatment for psychiatric conditions has gained interest due to their potential to modulate the gut-brain axis. This review aims to assess the effectiveness of these interventions in reducing symptoms of depression and anxiety in psychiatric populations.

Objective: The aim was to comprehensively review and appraise the effectiveness of prebiotic, probiotic, and synbiotic interventions in reducing clinical depression and anxiety symptoms.

View Article and Find Full Text PDF

Objective: Identification of therapeutic targets in the treatment of adolescent depression with attenuated symptoms of schizophrenia and assessment of the effectiveness of therapeutic interventions.

Material And Methods: One hundred and twenty-three patients (mean age 19.6±2.

View Article and Find Full Text PDF

Objective: To analyze the subjective sleep assessment in patients with neuromyelitis optica spectrum diseases (NMOSD) according to the current disease criteria of 2015.

Material And Methods: Twenty patients (17 women and 3 men), median age 44.5 years [Q:Q=27.

View Article and Find Full Text PDF

Objective: To study the quality of life (QoL) of patients with multiple sclerosis (MS) in the Smolensk region who receive MS disease-modifying therapies (DMT).

Material And Methods: The study included 37 patients receiving MS DMT. The 36-Item Short Form Health Survey (SF-36), the Multiple sclerosis Quality of Life (MusiQol), the Hamilton Depression Rating Scale, a scale of satisfaction with treatment, the Fatigue Severity Scale were administered.

View Article and Find Full Text PDF

Background: Reliable gender-sensitive normative data is needed to facilitate mental health research and clinical utility of commonly used symptoms scales. This study establishes Danish gender-stratified norms for the 53-item and 18-item Brief Symptom Inventory (BSI-53, BSI-18), proposed attention deficit hyperactivity disorder (ADHD) symptomatology scales from the BSI-53, and the 10-item Symptom Checklist (SCL-10). This study also examines gender-differences in symptom reporting of the ADHD and SCL-10 scales, and assesses potential bias in recent SCL-10 norms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!